JPWO2020191270A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020191270A5 JPWO2020191270A5 JP2021556435A JP2021556435A JPWO2020191270A5 JP WO2020191270 A5 JPWO2020191270 A5 JP WO2020191270A5 JP 2021556435 A JP2021556435 A JP 2021556435A JP 2021556435 A JP2021556435 A JP 2021556435A JP WO2020191270 A5 JPWO2020191270 A5 JP WO2020191270A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- stable liquid
- liquid pharmaceutical
- antibody
- uplc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962821661P | 2019-03-21 | 2019-03-21 | |
| US62/821,661 | 2019-03-21 | ||
| PCT/US2020/023795 WO2020191270A1 (en) | 2019-03-21 | 2020-03-20 | Stabilized formulations containing anti-il-33 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526292A JP2022526292A (ja) | 2022-05-24 |
| JPWO2020191270A5 true JPWO2020191270A5 (zh) | 2023-03-24 |
Family
ID=70228884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556435A Pending JP2022526292A (ja) | 2019-03-21 | 2020-03-20 | 抗ｉｌ－３３抗体を含有する安定化製剤 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11596690B2 (zh) |
| EP (1) | EP3941522A1 (zh) |
| JP (1) | JP2022526292A (zh) |
| KR (1) | KR20210141592A (zh) |
| CN (1) | CN113573733A (zh) |
| AU (1) | AU2020241882A1 (zh) |
| BR (1) | BR112021018727A2 (zh) |
| CA (1) | CA3133995A1 (zh) |
| CL (1) | CL2021002440A1 (zh) |
| CO (1) | CO2021011648A2 (zh) |
| EA (1) | EA202192568A1 (zh) |
| IL (1) | IL286024A (zh) |
| MA (1) | MA55362A (zh) |
| MX (1) | MX2021011137A (zh) |
| SA (1) | SA521430229B1 (zh) |
| SG (1) | SG11202109822XA (zh) |
| TW (1) | TW202102260A (zh) |
| WO (1) | WO2020191270A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021015034A2 (pt) | 2019-02-18 | 2021-10-05 | Eli Lilly And Company | Formulação de anticorpo terapêutico |
| BR112022022620A2 (pt) * | 2020-05-11 | 2022-12-20 | Medimmune Ltd | Formulações de anticorpos anti-il-33 |
| WO2023077685A1 (zh) * | 2021-11-04 | 2023-05-11 | 江苏荃信生物医药股份有限公司 | 包含抗人白介素-33单克隆抗体的浓缩溶液的制备方法及液体制剂 |
| CN113842457B (zh) * | 2021-11-04 | 2022-05-20 | 江苏荃信生物医药股份有限公司 | 包含抗人白介素-33单克隆抗体的液体制剂 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0747045B2 (ja) | 1986-10-15 | 1995-05-24 | 株式会社大協精工 | 積層した注射器用滑栓 |
| JP3100727B2 (ja) | 1992-01-23 | 2000-10-23 | 株式会社大協精工 | 変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品 |
| JP3172057B2 (ja) | 1995-04-05 | 2001-06-04 | 株式会社大協精工 | ラミネートゴム栓 |
| JP3512349B2 (ja) | 1999-01-29 | 2004-03-29 | 株式会社大協精工 | 柱状ゴム要素の成形型 |
| MXPA02008472A (es) * | 2000-03-03 | 2004-03-26 | Cambridge Antibody Tech | Anticuerpos humanos contra la eotaxina y su uso. |
| JP2002209975A (ja) | 2001-01-19 | 2002-07-30 | Daikyo Seiko Ltd | 医薬バイアル用ラミネートゴム栓 |
| NZ549040A (en) | 2004-02-17 | 2009-07-31 | Schering Corp | Use for interleukin-33 (IL33) and the IL-33 receptor complex |
| JO3000B1 (ar) * | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| GB0600351D0 (en) * | 2006-01-10 | 2006-02-15 | Weston Terence E | Safe hypodermic needle |
| IE20080331A1 (en) | 2007-04-26 | 2009-07-08 | Trinity College Dublin | Products for altering cytokine activity and methods therefor |
| US20100260770A1 (en) | 2007-05-18 | 2010-10-14 | Medimmune, Llc | Il-33 in inflammatory disease |
| WO2011031600A1 (en) | 2009-09-10 | 2011-03-17 | Schering Corporation | Use of il-33 antagonists to treat fibrotic disease |
| BR112013008366B1 (pt) * | 2010-10-06 | 2022-02-08 | Regeneron Pharmaceuticals, Inc | Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações |
| US9321829B2 (en) * | 2011-10-18 | 2016-04-26 | Emory University | Antibodies directed against influenza |
| US8883979B2 (en) * | 2012-08-31 | 2014-11-11 | Bayer Healthcare Llc | Anti-prolactin receptor antibody formulations |
| SG11201501011WA (en) * | 2012-09-07 | 2015-03-30 | Regeneron Pharma | Methods for treating atopic dermatitis by administering an il-4r antagonist |
| JO3532B1 (ar) | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| MA50638A (fr) | 2015-10-06 | 2020-08-05 | Regeneron Pharma | Biomarqueurs associés aux maladies médiées par l'interleukine-33 (il-33) et leurs utilisations |
| TWI784988B (zh) * | 2016-12-01 | 2022-12-01 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
| UA123847C2 (uk) * | 2017-03-16 | 2021-06-09 | Лг Кем, Лтд. | Рідка композиція анти-tnf альфа антитіла |
| EP3966227A1 (en) * | 2019-05-07 | 2022-03-16 | Voyager Therapeutics, Inc. | Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation |
| CN112851814B (zh) * | 2020-03-17 | 2023-07-07 | 西安宇繁生物科技有限责任公司 | 一种靶向bcma的全人源单链抗体及其制备方法与应用 |
| EP4255451A1 (en) * | 2020-12-03 | 2023-10-11 | The Board Of Regents Of The University Of Texas System | Methods for identifying lilrb-blocking antibodies |
| TW202237639A (zh) * | 2020-12-09 | 2022-10-01 | 日商武田藥品工業股份有限公司 | 鳥苷酸環化酶ｃ（ｇｃｃ）抗原結合劑之組成物及其使用方法 |
-
2020
- 2020-03-19 TW TW109109133A patent/TW202102260A/zh unknown
- 2020-03-20 EP EP20718107.4A patent/EP3941522A1/en active Pending
- 2020-03-20 CA CA3133995A patent/CA3133995A1/en active Pending
- 2020-03-20 EA EA202192568A patent/EA202192568A1/ru unknown
- 2020-03-20 MX MX2021011137A patent/MX2021011137A/es unknown
- 2020-03-20 KR KR1020217033469A patent/KR20210141592A/ko unknown
- 2020-03-20 BR BR112021018727A patent/BR112021018727A2/pt unknown
- 2020-03-20 JP JP2021556435A patent/JP2022526292A/ja active Pending
- 2020-03-20 MA MA055362A patent/MA55362A/fr unknown
- 2020-03-20 CN CN202080021576.XA patent/CN113573733A/zh active Pending
- 2020-03-20 AU AU2020241882A patent/AU2020241882A1/en active Pending
- 2020-03-20 SG SG11202109822X patent/SG11202109822XA/en unknown
- 2020-03-20 WO PCT/US2020/023795 patent/WO2020191270A1/en active Application Filing
- 2020-03-20 US US16/825,007 patent/US11596690B2/en active Active
-
2021
- 2021-09-01 IL IL286024A patent/IL286024A/en unknown
- 2021-09-02 CO CONC2021/0011648A patent/CO2021011648A2/es unknown
- 2021-09-05 SA SA521430229A patent/SA521430229B1/ar unknown
- 2021-09-20 CL CL2021002440A patent/CL2021002440A1/es unknown
-
2023
- 2023-02-03 US US18/105,772 patent/US20230346929A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6396565B2 (ja) | 抗インターロイキン−４受容体（ｉｌ−４ｒ）抗体を含有する安定化製剤 | |
| KR102667484B1 (ko) | 안정한 항체 제형 | |
| JP6456470B2 (ja) | 抗ｐｃｓｋ９抗体を含む安定化製剤 | |
| AU2016204515B2 (en) | Stabilized formulations containing anti-ngf antibodies | |
| JP2016020371A (ja) | 抗インターロイキン６受容体（ｉｌ−６ｒ）抗体を含有する安定化製剤 | |
| AU2013267301B2 (en) | Stabilized formulations containing anti-Dll4 antibodies | |
| AU2020241882A1 (en) | Stabilized formulations containing anti-iL-33 antibodies | |
| TWI568445B (zh) | 含有液態醫藥配製物之預填充針筒 | |
| JPWO2020191270A5 (zh) | ||
| JP2023511080A (ja) | 安定な抗体製剤 | |
| JPWO2022010988A5 (zh) | ||
| TWI856388B (zh) | 含有抗-介白素-4受體(il-4r)抗體之安定化配製物 | |
| EA047546B1 (ru) | Стабилизированные составы, содержащие антитела анти-pcsk9 | |
| EA042167B1 (ru) | Стабилизированные композиции, содержащие антитела к рецептору интерлейкина-4 (il-4r) |